Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 2Neoplasms 2Sepsis 1Rectal Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Inflammation 1Infections 1Febrile Neutropenia 1Emergencies 1Discitis 1Colorectal Neoplasms 1

Interventions

Capecitabine 13Fluorouracil 11Oxaliplatin 10Bevacizumab 9Leucovorin 6Irinotecan 6HMPL-013 4Folfox protocol 4Cetuximab 4ferric carboxymaltose 3regorafenib 2gadolinium ethoxybenzyl DTPA 2gadobenic acid 2Triamcinolone 2Standard of Care 2Sodium Chloride 2Radiofrequency Ablation 2Pirinitramide 2Morphine 2Esomeprazole 2Analgesia, Epidural 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1sodium phosphate 1raltitrexed 1polyethylene glycol 3350 1iron isomaltoside 1000 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1gadoteridol 1gadoterate meglumine 1gadodiamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Colorectal Neoplasms × Anti-Bacterial Agents × Clear all
NCT04281667 2022-11-17

MOBILE2

Helsinki University Central Hospital

Phase 4 Active not recruiting
604 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡